Biolase's average Accounts Receivable for the
three
months ended in Dec. 2023 was $4.94 Mil. Biolase's Revenue for the
three
months ended in Dec. 2023 was $13.49 Mil.
Hence, Biolase's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 33.39.
The historical rank and industry rank for Biolase's Days Sales Outstanding or its related term are showing as below:
BIOL'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.98 Med: 72.34 Max: 95.95
Current: 39.48
During the past 13 years, Biolase's highest Days Sales Outstanding was 95.95. The lowest was 33.98. And the median was 72.34.
BIOL's Days Sales Outstanding is ranked better than 84.26% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 63.94
vs BIOL: 39.48
Biolase's Days Sales Outstanding
declined
from Dec. 2022 (34.70) to Dec. 2023 (33.39).
Biolase Days Sales Outstanding Historical Data
The historical data trend for Biolase's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biolase's Days Sales Outstanding
For the Medical Devices subindustry, Biolase's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biolase's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biolase's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Biolase's Days Sales Outstanding falls into.
Biolase Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biolase (NAS:BIOL) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Biolase Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Biolase's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIOL has been successfully added to your 